spiperone has been researched along with 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bédard, PJ; Di Paolo, T; Rouillard, C | 1 |
| Bruno, JP; Hadjiconstantinou, M; Neff, NH; Weihmuller, FB | 1 |
2 other study(ies) available for spiperone and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone | 1990 |
Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; In Vitro Techniques; Kinetics; Male; Mice; Receptors, Dopamine; Spiperone; Substantia Nigra; Up-Regulation | 1990 |